abrdn Healthcare Opportunities Fund is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2014-07-25. abrdn Healthcare Opportunities Fund (the Fund) is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests primarily in equity and debt in securities of public and private United States (U.S.) and non-U.S. companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Fund will not invest more than 20%, as measured at the time of investment, in convertible securities. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. The company invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is abrdn Inc.
根据最新的财务报表(Form-10K),abrdn Healthcare Opportunities Fund 的总资产为 $970,净损失为 $-115
THQ 的关键财务比率是什么?
abrdn Healthcare Opportunities Fund 的流动比率是 4.21,净利 margin 为 -547.61,每股销售为 $0.51。
abrdn Healthcare Opportunities Fund 的收入按细分市场或地理位置如何划分?
abrdn Healthcare Opportunities Fund 最大收入来源是 Lending,在最近的收益报告中收入为 1,848,949,000。就地区而言, United States 是 abrdn Healthcare Opportunities Fund 的主要市场,收入为 2,576,456,000。
abrdn Healthcare Opportunities Fund 是否盈利?
不,根据最新的财务报表,abrdn Healthcare Opportunities Fund 的净损失为 $-115